This is a Validated Antibody Database (VAD) review about human CRY1, based on 6 published articles (read how Labome selects the articles), using CRY1 antibody in all methods. It is aimed to help Labome visitors find the most suited CRY1 antibody. Please note the number of articles fluctuates since newly identified citations are added and citations for discontinued catalog numbers are removed regularly.
CRY1 synonym: DSPD; PHLL1

Santa Cruz Biotechnology
mouse monoclonal (W-L5)
  • proximity ligation assay; mouse; 1:250; loading ...; fig 5f
  • western blot; mouse; loading ...; fig 1a
Santa Cruz Biotechnology CRY1 antibody (Santa Cruz Biotechnology Inc, sc-101006) was used in proximity ligation assay on mouse samples at 1:250 (fig 5f) and in western blot on mouse samples (fig 1a). Diabetes (2017) ncbi
mouse monoclonal (W-L5)
  • immunohistochemistry - paraffin section; human; 1:200; tbl 3
Santa Cruz Biotechnology CRY1 antibody (santa Cruz, sc-101006) was used in immunohistochemistry - paraffin section on human samples at 1:200 (tbl 3). BMC Cancer (2016) ncbi
mouse monoclonal (W-L5)
  • western blot; human; 1:100; fig 1
Santa Cruz Biotechnology CRY1 antibody (Santa Cruz Biotechnology, SC-101006) was used in western blot on human samples at 1:100 (fig 1). PLoS ONE (2015) ncbi
Invitrogen
domestic rabbit polyclonal
  • western blot; rat; loading ...; fig 4c
In order to show decreased Bmal1 in GLAST-positive astrocytes alters circadian locomotor behavior and cognition in mice, Invitrogen CRY1 antibody (Thermo Fisher, PA5-13124) was used in western blot on rat samples (fig 4c). Nat Commun (2017) ncbi
Abcam
domestic rabbit polyclonal
  • western blot; human; 1:1000; fig s1c
In order to demonstrate that MYC persistently upregulates REV-ERBalpha, Abcam CRY1 antibody (Abcam, ab104736) was used in western blot on human samples at 1:1000 (fig s1c). Nat Commun (2017) ncbi
Abnova
mouse monoclonal (4H4-1C4)
  • western blot; human; loading ...; fig 1a
Abnova CRY1 antibody (Abnova, 4H4-1C4) was used in western blot on human samples (fig 1a). Proc Natl Acad Sci U S A (2016) ncbi
Articles Reviewed
  1. Tong X, Zhang D, Charney N, Jin E, VanDommelen K, Stamper K, et al. DDB1-Mediated CRY1 Degradation Promotes FOXO1-Driven Gluconeogenesis in Liver. Diabetes. 2017;66:2571-2582 pubmed publisher
  2. Altman B, Hsieh A, Gouw A, Dang C. Correspondence: Oncogenic MYC persistently upregulates the molecular clock component REV-ERB?. Nat Commun. 2017;8:14862 pubmed publisher
  3. Barca Mayo O, Pons Espinal M, Follert P, Armirotti A, Berdondini L, De Pietri Tonelli D. Astrocyte deletion of Bmal1 alters daily locomotor activity and cognitive functions via GABA signalling. Nat Commun. 2017;8:14336 pubmed publisher
  4. Gotoh T, Kim J, Liu J, Vila Caballer M, Stauffer P, Tyson J, et al. Model-driven experimental approach reveals the complex regulatory distribution of p53 by the circadian factor Period 2. Proc Natl Acad Sci U S A. 2016;113:13516-13521 pubmed
  5. Litlekalsoy J, Rostad K, Kalland K, Hostmark J, Laerum O. Expression of circadian clock genes and proteins in urothelial cancer is related to cancer-associated genes. BMC Cancer. 2016;16:549 pubmed publisher
  6. Tong X, Zhang D, Guha A, Arthurs B, Cazares V, Gupta N, et al. CUL4-DDB1-CDT2 E3 Ligase Regulates the Molecular Clock Activity by Promoting Ubiquitination-Dependent Degradation of the Mammalian CRY1. PLoS ONE. 2015;10:e0139725 pubmed publisher